University of Heidelberg, Department of Anesthesiology, Heidelberg Medical School
Heidelberg, Baden-Wurttemberg, 69120, Germany
NCT Number: NCT00782938
Drugs with anticholinergic potential increase the risk of postoperative transient and persistent cognitive dysfunction especially in cardiac patients. The investigators main goal is to identify preoperative risk factors and to monitor postoperative patients' state in relation to SAA activity and bilateral BIS-EEG changes.
Looking for future studies?
Notify Me55 year–90 year
All sexes
Observational
Heidelberg, Baden-Wurttemberg, 69120, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 month postsurgery
Time frame: 24 h postsurgery
Heidelberg University
Other
Serum Anticholinergic Activity (SAA) and BIS-EEG as Potential Markers for Cognitive Ability and/or the Anticholinergic Medication in ACVB Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04291144
Acetylcholine, Basal Ganglia Diseases
Aarhus N, Denmark
View Trial DetailsNCT01003535
Acetylcholine, Basal Ganglia Diseases
Homburg/Saar, Saarland, Germany
View Trial DetailsNCT07103317
ANOCA, ANOCA - Angina With Non-obstructive Coronary Arteries
Prague, Česká Republika, Czechia
View Trial DetailsNCT05912556
Brain Function, Brain Health
San Francisco, California, United States
View Trial Details